ADAMAS PHARMACEUTICALS INC's ticker is ADMS and the CUSIP is 00548A106. A total of 100 filers reported holding ADAMAS PHARMACEUTICALS INC in Q1 2019. The put-call ratio across all filers is 2.58 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2019 | $2,735,000 | -84.4% | 441,088 | -82.1% | 0.60% | -83.6% |
| Q1 2019 | $17,561,000 | -21.3% | 2,469,894 | -5.5% | 3.63% | +23.5% |
| Q4 2018 | $22,328,000 | -16.0% | 2,614,468 | +96.8% | 2.94% | -25.0% |
| Q3 2018 | $26,595,000 | -27.3% | 1,328,424 | -6.3% | 3.91% | -32.1% |
| Q2 2018 | $36,604,000 | +34.9% | 1,417,121 | +24.8% | 5.76% | +36.3% |
| Q1 2018 | $27,131,000 | – | 1,135,203 | – | 4.23% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Stonepine Capital Management, LLC | 1,423,578 | $8,826,000 | 6.08% |
| Healthcare Value Capital, LLC | 200,000 | $1,240,000 | 2.33% |
| ARMISTICE CAPITAL, LLC | 2,700,000 | $16,740,000 | 1.06% |
| DELTEC ASSET MANAGEMENT LLC | 550,836 | $3,415,000 | 0.75% |
| Broadfin Capital, LLC | 441,088 | $2,735,000 | 0.60% |
| Kerrisdale Advisers, LLC | 229,347 | $1,422,000 | 0.51% |
| Worth Venture Partners, LLC | 87,908 | $545,000 | 0.30% |
| Mosaic Family Wealth, LLC | 91,314 | $566,000 | 0.24% |
| EMERALD ADVISERS, LLC | 700,176 | $4,341,000 | 0.17% |
| EMERALD MUTUAL FUND ADVISERS TRUST | 616,664 | $3,823,000 | 0.15% |